chr12-2679502-C-G

Variant names:

• chr12-2679502-C-G
• rs201492706
• NM_000719.7:c.5150C>G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_Strong BP6 BS1 BS2

The NM_000719.7(CACNA1C):​c.5150C>G​(p.Ala1717Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000588 in 1,609,272 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1717V) has been classified as Likely benign.

• Frequency:
  • Genomes: 𝑓 0.00050 (0 hom., cov: 33)
  • Exomes 𝑓: 0.00060 (5 hom.)
• Consequence: CACNA1C NM_000719.7 missense
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4 B:9
• Conservation: PhyloP100: 3.62
• Publications: 9 publications found

Genes affected

CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]

ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)

CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

ACMG classification

Our verdict: Benign. The variant received -13 ACMG points.

• BP4: Computational evidence support a benign effect (MetaRNN=0.0071842372).
• BP6: Variant 12-2679502-C-G is Benign according to our data. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411. Variant chr12-2679502-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 93411.
• BS1: Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000499 (76/152314) while in subpopulation AMR AF = 0.00098 (15/15302). AF 95% confidence interval is 0.000604. There are 0 homozygotes in GnomAd4. There are 32 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
• BS2: High AC in GnomAd4 at 76 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CACNA1C	NM_000719.7	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 47	ENST00000399655.6	NP_000710.5
CACNA1C	NM_001167623.2	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 47	ENST00000399603.6	NP_001161095.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CACNA1C	ENST00000399603.6	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 47	5	NM_001167623.2	ENSP00000382512.1
CACNA1C	ENST00000399655.6	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 47	1	NM_000719.7	ENSP00000382563.1
CACNA1C	ENST00000682544.1	c.5384C>G	p.Ala1795Gly	missense_variant	Exon 44 of 50			ENSP00000507184.1
CACNA1C	ENST00000406454.8	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 48	5		ENSP00000385896.3
CACNA1C	ENST00000399634.6	c.5117C>G	p.Ala1706Gly	missense_variant	Exon 41 of 47	5		ENSP00000382542.2
CACNA1C	ENST00000683824.1	c.5315C>G	p.Ala1772Gly	missense_variant	Exon 43 of 48			ENSP00000507867.1
CACNA1C	ENST00000347598.9	c.5294C>G	p.Ala1765Gly	missense_variant	Exon 44 of 49	1		ENSP00000266376.6
CACNA1C	ENST00000344100.7	c.5273C>G	p.Ala1758Gly	missense_variant	Exon 42 of 47	1		ENSP00000341092.3
CACNA1C	ENST00000327702.12	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 48	1		ENSP00000329877.7
CACNA1C	ENST00000399617.6	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 48	5		ENSP00000382526.1
CACNA1C	ENST00000682462.1	c.5240C>G	p.Ala1747Gly	missense_variant	Exon 42 of 47			ENSP00000507105.1
CACNA1C	ENST00000683781.1	c.5240C>G	p.Ala1747Gly	missense_variant	Exon 42 of 47			ENSP00000507434.1
CACNA1C	ENST00000683840.1	c.5240C>G	p.Ala1747Gly	missense_variant	Exon 42 of 47			ENSP00000507612.1
CACNA1C	ENST00000683956.1	c.5240C>G	p.Ala1747Gly	missense_variant	Exon 42 of 47			ENSP00000506882.1
CACNA1C	ENST00000399638.5	c.5234C>G	p.Ala1745Gly	missense_variant	Exon 43 of 48	1		ENSP00000382547.1
CACNA1C	ENST00000335762.10	c.5225C>G	p.Ala1742Gly	missense_variant	Exon 43 of 48	5		ENSP00000336982.5
CACNA1C	ENST00000399606.5	c.5210C>G	p.Ala1737Gly	missense_variant	Exon 43 of 48	1		ENSP00000382515.1
CACNA1C	ENST00000399621.5	c.5207C>G	p.Ala1736Gly	missense_variant	Exon 42 of 47	1		ENSP00000382530.1
CACNA1C	ENST00000399637.5	c.5207C>G	p.Ala1736Gly	missense_variant	Exon 42 of 47	1		ENSP00000382546.1
CACNA1C	ENST00000402845.7	c.5207C>G	p.Ala1736Gly	missense_variant	Exon 42 of 47	1		ENSP00000385724.3
CACNA1C	ENST00000399629.5	c.5201C>G	p.Ala1734Gly	missense_variant	Exon 42 of 47	1		ENSP00000382537.1
CACNA1C	ENST00000682336.1	c.5192C>G	p.Ala1731Gly	missense_variant	Exon 42 of 47			ENSP00000507898.1
CACNA1C	ENST00000399591.5	c.5174C>G	p.Ala1725Gly	missense_variant	Exon 41 of 46	1		ENSP00000382500.1
CACNA1C	ENST00000399595.5	c.5174C>G	p.Ala1725Gly	missense_variant	Exon 41 of 46	1		ENSP00000382504.1
CACNA1C	ENST00000399649.5	c.5168C>G	p.Ala1723Gly	missense_variant	Exon 41 of 46	1		ENSP00000382557.1
CACNA1C	ENST00000399597.5	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 47	1		ENSP00000382506.1
CACNA1C	ENST00000399601.5	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 47	1		ENSP00000382510.1
CACNA1C	ENST00000399641.6	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 47	1		ENSP00000382549.1
CACNA1C	ENST00000399644.5	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 47	1		ENSP00000382552.1
CACNA1C	ENST00000682835.1	c.5150C>G	p.Ala1717Gly	missense_variant	Exon 42 of 47			ENSP00000507282.1
CACNA1C	ENST00000683482.1	c.5141C>G	p.Ala1714Gly	missense_variant	Exon 42 of 47			ENSP00000507169.1
CACNA1C	ENST00000682686.1	c.5117C>G	p.Ala1706Gly	missense_variant	Exon 41 of 46			ENSP00000507309.1

Frequencies

GnomAD3 genomes AF: 0.000499 AC: 76 AN: 152196 Hom.: 0 Cov.: 33

Gnomad AFR AF: 0.000121

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.000982

Gnomad ASJ AF: 0.00432

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.000207

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.00

Gnomad NFE AF: 0.000514

Gnomad OTH AF: 0.00239

GnomAD2 exomes AF: 0.000846 AC: 206 AN: 243628 AF XY: 0.000921

Gnomad AFR exome AF: 0.00

Gnomad AMR exome AF: 0.00123

Gnomad ASJ exome AF: 0.00629

Gnomad EAS exome AF: 0.00

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.000663

Gnomad OTH exome AF: 0.00168

GnomAD4 exome AF: 0.000597 AC: 870 AN: 1456958 Hom.: 5 Cov.: 31 AF XY: 0.000641 AC XY: 464 AN XY: 724114

African (AFR) AF: 0.000390 AC: 13 AN: 33336

American (AMR) AF: 0.00128 AC: 57 AN: 44360

Ashkenazi Jewish (ASJ) AF: 0.00659 AC: 171 AN: 25968

East Asian (EAS) AF: 0.00 AC: 0 AN: 39576

South Asian (SAS) AF: 0.000559 AC: 48 AN: 85926

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 53066

Middle Eastern (MID) AF: 0.00852 AC: 49 AN: 5752

European-Non Finnish (NFE) AF: 0.000410 AC: 455 AN: 1108784

Other (OTH) AF: 0.00128 AC: 77 AN: 60190

GnomAD4 genome AF: 0.000499 AC: 76 AN: 152314 Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 32 AN XY: 74478

African (AFR) AF: 0.000120 AC: 5 AN: 41574

American (AMR) AF: 0.000980 AC: 15 AN: 15302

Ashkenazi Jewish (ASJ) AF: 0.00432 AC: 15 AN: 3472

East Asian (EAS) AF: 0.00 AC: 0 AN: 5172

South Asian (SAS) AF: 0.000207 AC: 1 AN: 4828

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 10626

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 294

European-Non Finnish (NFE) AF: 0.000515 AC: 35 AN: 68020

Other (OTH) AF: 0.00237 AC: 5 AN: 2114

Alfa AF: 0.00107 Hom.: 0

Bravo AF: 0.000646

TwinsUK AF: 0.00 AC: 0

ALSPAC AF: 0.000259 AC: 1

ExAC AF: 0.000595 AC: 72

Asia WGS AF: 0.000289 AC: 1 AN: 3478

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:4 Benign:9

Revision: criteria provided, conflicting classifications

Submissions by phenotype

not provided Uncertain:1 Benign:3

Jan 18, 2021

GeneDx

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 22840528, 20817017) -

Feb 06, 2015

Eurofins Ntd Llc (ga)

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

May 01, 2025

CeGaT Center for Human Genetics Tuebingen

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

CACNA1C: BS1 -

Jun 24, 2013

Biesecker Lab/Clinical Genomics Section, National Institutes of Health

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: research

- -

Long QT syndrome Uncertain:1 Benign:1

Jan 31, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Jan 08, 2024

Dept of Medical Biology, Uskudar University

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: research

Criteria: BS1, PP2 -

not specified Benign:2

Apr 09, 2025

Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Mar 18, 2019

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Variant summary: CACNA1C c.5150C>G (p.Ala1717Gly) results in a non-conservative amino acid change located in the Voltage-gated calcium channel subunit alpha, C-terminal of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00076 in 272838 control chromosomes in the gnomAD database, including 1 homozygotes. The observed variant frequency is approximately 75.87 fold of the estimated maximal expected allele frequency for a pathogenic variant in CACNA1C causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is benign. c.5150C>G has been reported in the literature in individuals affected with cardiac phenotypes (Burashnikov_2010, Crotti_2012, Forleo_2017, Kostareva_2016, Wemhoner_2015) however without strong evidence for causality. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Based on the evidence outlined above, the variant was classified as likely benign. -

Timothy syndrome;C2678478:Brugada syndrome 3;C5774213:Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures;CN260585:Long qt syndrome 8 Uncertain:1

-

Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

CACNA1C NM_000719.6 exon 42 p.Ala1717Gly (c.5150C>G): This variant has not been reported in the literature but is present in 0.1% (41/34056) of Latino alleles, including 1 homozygote, in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs201492706). This variant is present in ClinVar, with several labs classifying this variant as Likely Benign (Variation ID:93411). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore this variant is classified as Likely Benign -

Restrictive cardiomyopathy;C0023976:Long QT syndrome Uncertain:1

Jun 24, 2014

Blueprint Genetics

Significance: Uncertain significance

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

CACNA1C-related disorder Benign:1

Feb 16, 2024

PreventionGenetics, part of Exact Sciences

Significance: Likely benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Brugada syndrome Benign:1

Aug 01, 2016

CSER _CC_NCGL, University of Washington

Significance: Likely benign

Review Status: no assertion criteria provided

Collection Method: research

Found in patient having exome sequencing for an unrelated indication. No known history of Brugada syndrome. -

Cardiovascular phenotype Benign:1

Jun 28, 2018

Ambry Genetics

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
CardioboostArm	Benign	0.0000011
BayesDel_addAF	Benign	-0.30	T
BayesDel_noAF	Benign	-0.25
CADD	Benign	22
DANN	Uncertain	0.99
DEOGEN2	Benign	0.012	T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;T
Eigen	Benign	-0.32
Eigen_PC	Benign	-0.14
FATHMM_MKL	Uncertain	0.92	D
M_CAP	Benign	0.080	D
MetaRNN	Benign	0.0072	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM	Uncertain	-0.0047	T
MutationAssessor	Benign	-0.20	.;.;.;.;.;.;.;.;.;.;N;.;.;.;.;.;.;.;.;.;.;.;.
PhyloP100		3.6
PrimateAI	Benign	0.29	T
PROVEAN	Benign	-1.1	N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;.
REVEL	Benign	0.27
Sift	Benign	0.059	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;D;T;T;T;D;D;D;.
Sift4G	Benign	0.43	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen		0.0, 0.026, 0.0040	.;B;B;B;B;B;B;B;B;B;B;B;B;B;B;.;B;B;.;.;.;B;.
Vest4		0.15
MVP		0.59
MPC		0.19
ClinPred		0.021	T
GERP RS		3.7
gMVP		0.43
Mutation Taster		=100/0	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs201492706; hg19: chr12-2788668;